Press Releases February 3, 2026: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…MaaT PharmaFebruary 3, 2026
Press Releases January 20, 2026: MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy,…MaaT PharmaJanuary 20, 2026
